Skip to content
National Cancer Institute
U.S. National Institutes of Health
| www.cancer.gov
In English |
En español
Search
NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Clinical Trials Search Results
Quick Links
Director's Corner
Dictionary of Cancer Terms
NCI Drug Dictionary
Funding Opportunities
NCI Publications
Advisory Boards and Groups
Science Serving People
Español
Questions about cancer?
1-800-4-CANCER
LiveHelp® online chat
NCI Highlights
High Dose Chemotherapy Prolongs Survival for Leukemia
Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E
Past Highlights
Results:
1 -10 of 71
Show
10
25
50
100
200
results per page
View Search Criteria
|
Help With Results
Sort By:
Phase of Trial
Title
Type of Trial
Status of Trial
Age Range
Sponsor of Trial
Protocol IDs
Version:
Health Professional
Patient
Format:
Short
------
Short
Medium
Long
Custom
1.
Phase II/III Chemotherapy and Hormone Therapy with ADR/VCR/DBD/PRED Followed by TMX/FXM/BLEO/HMM/MTX-CF for Metastatic Stage III/IV or Recurrent Breast Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Closed
under 65
WCCC-CO-7711R
NCI-D80-048-183
Last Modified:
5/15/2007
2.
Phase III Chemotherapy with Various Schedules of ADR for Soft Tissue and Bone Sarcoma and Mesothelioma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
14 to 75
NCI
EST-3377
3.
Phase III Chemotherapy with Adriamycin/Dibromodulcitol vs Adriamycin Alone for Resistant Advanced Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III, Phase II
Treatment
Completed
postmenopausal
MAYO-793251
NCCTG-793251
Last Modified:
2/8/2008
 
First Published:
2/1/1995
4.
Phase III Randomized Study of Radiotherapy with DBD Radiosensitization Followed by DBD/BCNU vs Radiotherapy Alone for Anaplastic Astrocytomas
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
over 16
EORTC-26882
NCT00002620
5.
AC (ADR/CTX) Followed by CMFP (CTX/MTX/5-FU/PRED) or CMFP (DBD/MTX/5-FU/PRED) Both Alternating with AC for Metastatic Breast Carcinoma
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
under 70
NCI-D78-017-074
Last Modified:
8/9/2007
6.
L-ASP/PRED/VCR/ARA-C/ADR, DBD or CTX Plus Intrathecal Prophylactic MTX/CF for Marrow Relapse in Children with ALL/AUL LEUKEMIA
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Closed
under 18
NCI
CCG-142A
Last Modified:
8/9/2007
7.
L-ASP/PRED/VCR/ARA-C/ADR, DBD OR CTX, Plus Intrathecal ARA-C/HC/MTX/CF for Marrow and CNS Relapse in Children with ALL/AUL
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
under 18
NCI
CCG-142B
Last Modified:
4/10/2007
8.
Phase III Induction with DAVTH (DBD/ADR/VCR/TMX/HAL) plus Randomized Maintenance for Metastatic or Recurrent Breast Cancer in Men and Women
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
no age specified
NCI
EST-2181
Last Modified:
4/10/2007
9.
Phase III Chemotherapy with DAVcH (DBD/ADR/VCR/HAL) vs TsAVbH (Thiotepa/ADR/VBL/HAL) for Disseminated or Recurrent Breast Cancer
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
no age specified
NCI
EST-6181
Last Modified:
11/18/2005
10.
Phase III Randomized Study of Chemohormonal Therapy with DATH (DBD/DOX/TMX/FXM) vs D(DHAD)TH (DBD/DHAD/TMX/FXM) in Patients with Previously Treated Metastatic Breast Cancer Who Have Had No Prior Exposure to Doxorubicin
Phase
Type
Status
Age
Sponsor
Protocol IDs
Phase III
Treatment
Completed
no age specified
NCI
EST-7181
Select All on One Page
1
2
3
4
Next >
NCI Home
|
Images Version
|
Contact Us
|
Policies
|
Accessibility
|
Viewing Files
|
FOIA
|
Site Help
|
Site Map
A Service of the National Cancer Institute